These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
606 related articles for article (PubMed ID: 22728279)
1. NGAL and NGALR overexpression in human hepatocellular carcinoma toward a molecular prognostic classification. Zhang Y; Fan Y; Mei Z Cancer Epidemiol; 2012 Oct; 36(5):e294-9. PubMed ID: 22728279 [TBL] [Abstract][Full Text] [Related]
3. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis. Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703 [TBL] [Abstract][Full Text] [Related]
4. NGAL and NGALR are frequently overexpressed in human gliomas and are associated with clinical prognosis. Liu MF; Jin T; Shen JH; Shen ZY; Zheng ZC; Zhang ZL; Xu LY; Li EM; Xu HX J Neurooncol; 2011 Aug; 104(1):119-27. PubMed ID: 21184133 [TBL] [Abstract][Full Text] [Related]
5. Notch1 and Notch4 are markers for poor prognosis of hepatocellular carcinoma. Ahn S; Hyeon J; Park CK Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):286-94. PubMed ID: 23742774 [TBL] [Abstract][Full Text] [Related]
6. Expression of NGAL and NGALR in human embryonic, fetal and normal adult tissues. Zhang PX; Zhang FR; Xie JJ; Tao LH; Lü Z; Xu XE; Shen J; Xu LY; Li EM Mol Med Rep; 2012 Oct; 6(4):716-22. PubMed ID: 22797813 [TBL] [Abstract][Full Text] [Related]
7. DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer. Song LJ; Liu Q; Meng XR; Li ShL; Wang LX; Fan QX; Xuan XY Diagn Pathol; 2016 Feb; 11():19. PubMed ID: 26846339 [TBL] [Abstract][Full Text] [Related]
8. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression. Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879 [TBL] [Abstract][Full Text] [Related]
9. Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) prognostic value in stage I colorectal carcinoma. Barresi V; Reggiani-Bonetti L; Di Gregorio C; Vitarelli E; Ponz De Leon M; Barresi G Pathol Res Pract; 2011 Aug; 207(8):479-86. PubMed ID: 21726963 [TBL] [Abstract][Full Text] [Related]
10. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients. Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282 [TBL] [Abstract][Full Text] [Related]
11. Role of Foxp3-positive tumor-infiltrating lymphocytes in the histologic features and clinical outcomes of hepatocellular carcinoma. Mathai AM; Kapadia MJ; Alexander J; Kernochan LE; Swanson PE; Yeh MM Am J Surg Pathol; 2012 Jul; 36(7):980-6. PubMed ID: 22446942 [TBL] [Abstract][Full Text] [Related]
12. The expression analysis of NGAL and NGALR in clear cell renal cell carcinoma. Liu F; Li N; Yang W; Wang R; Yu J; Wang X Gene; 2018 Nov; 676():269-278. PubMed ID: 30138675 [TBL] [Abstract][Full Text] [Related]
13. Expressions of neutrophil gelatinase-associated lipocalin in gastric cancer: a potential biomarker for prognosis and an ancillary diagnostic test. Wang HJ; He XJ; Ma YY; Jiang XT; Xia YJ; Ye ZY; Zhao ZS; Tao HQ Anat Rec (Hoboken); 2010 Nov; 293(11):1855-63. PubMed ID: 20730863 [TBL] [Abstract][Full Text] [Related]
14. Stromal expression of neutrophil gelatinase-associated lipocalin correlates with poor differentiation and adverse prognosis in oral squamous cell carcinoma. Shinriki S; Jono H; Ueda M; Obayashi K; Nakamura T; Ota K; Ota T; Sueyoshi T; Guo J; Hayashi M; Hiraki A; Nakayama H; Yamashita S; Shinohara M; Ando Y Histopathology; 2014 Feb; 64(3):356-64. PubMed ID: 24118080 [TBL] [Abstract][Full Text] [Related]
15. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis. Shi XM; Teng F Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma. Pan HW; Ou YH; Peng SY; Liu SH; Lai PL; Lee PH; Sheu JC; Chen CL; Hsu HC Cancer; 2003 Jul; 98(1):119-27. PubMed ID: 12833464 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of galectin-1 is associated with poor prognosis in human hepatocellular carcinoma following resection. Wu H; Chen P; Liao R; Li YW; Yi Y; Wang JX; Sun TW; Zhou J; Shi YH; Yang XR; Jin JJ; Cheng YF; Fan J; Qiu SJ J Gastroenterol Hepatol; 2012 Aug; 27(8):1312-9. PubMed ID: 22432916 [TBL] [Abstract][Full Text] [Related]
18. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection. Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469 [TBL] [Abstract][Full Text] [Related]
19. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma. Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285 [TBL] [Abstract][Full Text] [Related]
20. Down-regulation of neutrophil gelatinase-associated lipocalin in head and neck squamous cell carcinoma correlated with tumorigenesis, not with metastasis. Wang L; Chen C; Li F; Hua Q; Chen S; Xiao B; Dai M; Li M; Zheng A; Yu D; Hu Z; Tao Z Int J Clin Exp Pathol; 2015; 8(8):8857-68. PubMed ID: 26464627 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]